Filing Details
- Accession Number:
- 0001493152-21-014015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-10 16:01:44
- Reporting Period:
- 2021-06-03
- Accepted Time:
- 2021-06-10 16:01:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1457896 | William Ted Karkus | 711 Stewart Ave, Suite 200 Garden City, NY 11530 | Ceo & Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.005 | Acquisiton | 2021-06-03 | 33,943 | $5.07 | 2,333,471 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The transaction reported herein was an inadvertent purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program. The dividend reinvestment feature of the reporting person's brokerage account has since been removed.